[1]
|
Ross,W., Rowe,T., Glisson,B., Yalowich,J., & Liu,L. (1984) Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res., 44, 5857-5860.
|
[2]
|
Osheroff,N. (1989) Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. Biochemistry, 28, 6157-6160.
doi.org/10.1021/bi00441a005
|
[3]
|
Felix, C.A. (1998) Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta, 1400, 233-255. doi.org/10.1016/S0167-4781(98)00139-0
|
[4]
|
Felix, C.A., Hosler, M.R., Winick, N.J., Masterson, M., Wilson, A.E. and Lange, B.J. (1995) ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood, 85, 3250-3256.
|
[5]
|
Super, H.J., McCabe, N.R., Thirman, M.J., Larson, R.A., Le Beau, M.M., Pedersen-Bjergaard, J., Philip, P., Diaz, M.O. and Rowley, J.D. (1993) Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood, 82, 3705-3711.
|
[6]
|
Broeker, P.L., Super, H.G., Thirman, M.J., Pomykala, H., Yonebayashi, Y., Tanabe, S., Zeleznik-Le, N. and Rowley, J.D. (1996) Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood, 87, 1912-1922.
|
[7]
|
Huret J.L. MLL(myeloid/lymphoid or mixed lineage leukemia). Atlas Genet Cytogenet Oncol Haematol October 2005.
http://AtlasGeneticsOncology.org/Genes/MLL.html .
|
[8]
|
Nakamura, T., Alder, H., Gu, Y., Prasad, R., Canaani, O., Kamada, N., Gale, R.P., Lange, B., Crist, W.M. and Nowell, P.C. (1993) Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc. Natl. Acad. Sci. U. S. A, 90, 4631-4635.
doi.org/10.1073/pnas.90.10.4631
|
[9]
|
Super, H.G., Strissel, P.L., Sobulo, O.M., Burian, D., Reshmi, S.C., Roe, B., Zeleznik, L., Diaz, M.O. and Rowley, J.D. (1997) Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes. Cancer, 20, 185-195.
doi.org/10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#
|
[10]
|
Strissel, P.L., Strick, R., Tomek, R.J., Roe, B.A., Rowley, J.D. and Zeleznik, L. (2000) DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum. Mol Genet., 9, 1671-1679.
doi.org/10.1093/hmg/9.11.1671
|
[11]
|
Gu, Y., Alder, H., Nakamura, T., Schichman, S.A., Prasad, R., Canaani, O., Saito, H., Croce, C.M. and Canaani, E. (1994) Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res., 54, 2327-2330.
|
[12]
|
Gu, Y., Cimino, G., Alder, H., Nakamura, T., Prasad, R., Canaani, O., Moir,D.T., Jones, C., Nowell, P.C. and Croce, C.M. (1992) The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase. Proc. Natl. Acad. Sci. U. S. A, 89, 10464- 10468. doi.org/10.1073/pnas.89.21.10464
|
[13]
|
Strissel, P.L., Strick, R., Rowley, J.D. and Zeleznik, L. (1998) An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood, 92, 3793-3803.
|
[14]
|
Sim, S.P. and Liu, L.F. (2001) Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J. Biol. Chem., 276, 31590-31595.
doi.org/10.1074/jbc.M103962200
|
[15]
|
Sakahira, H., Enari, M., Ohsawa, Y., Uchiyama, Y. and Nagata, S. (1999) Apoptotic nuclear morphological change without DNA fragmentation. Curr. Biol., 9, 543-546. doi.org/10.1016/S0960-9822(99)80240-1
|
[16]
|
Vaughan, A.T., Betti, C.J. and Villalobos, M.J. (2002) Surviving apoptosis. Apoptosis., 7, 173-177.
doi.org/10.1023/A:1014374717773
|
[17]
|
Hars, E.S., Lyu, Y.L., Lin, C.P. and Liu, L.F. (2006) Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. Cancer Res., 66, 8975-8979.
doi.org/10.1158/0008-5472.CAN-06-1724
|
[18]
|
Klein,E., Ben Bassat,H., Neumann,H., Ralph,P., Zeuthen,J., Polliack,A., & Vanky,F. (1976) Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int. J. Cancer, 18, 421-431.
doi.org/10.1002/ijc.2910180405
|
[19]
|
Martins,L.M., Mesner,P.W., Kottke,T.J., Basi,G.S., Sinha,S., Tung,J.S., Svingen,P.A., Madden,B.J., Takahashi,A., McCormick,D.J., Earnshaw,W.C., & Kaufmann,S.H. (1997) Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood, 90, 4283-4296.
|
[20]
|
Widlak, P., Li, P., Wang, X. and Garrard, W.T. (2000) Cleavage preferences of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) on naked DNA and chromatin substrates. J Biol. Chem., 275, 8226-8232. doi.org/10.1074/jbc.275.11.8226
|
[21]
|
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular cloning: a laboratory manual, 2nd edition. Cold Spring Harbor Laboratory, Plainview, New York.
|
[22]
|
Watt, J.L.and S.G.S. (1986) Lymphocyte culture for chromosome analysis. In: Rooney, D.E. and Czepulkowski, B.H. Eds., Human cytogenetics: A practical approach, Oxford University Press, USA, 39-55.
|
[23]
|
Sakahira, H., Enari, M. and Nagata, S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature, 391, 96-99.
doi.org/10.1038/34214
|
[24]
|
Hsiang, Y.H., Wu, H.Y. and Liu, L.F. (1988) Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res., 48, 3230-3235.
|
[25]
|
Tamai, H. & Inokuchi, K. (2010) 11q23/MLL acute leukemia : update of clinical aspects. J. Clin. Exp. Hematop., 50, 91-98. doi.org/10.3960/jslrt.50.91
|
[26]
|
Atlas, M., Head, D., Behm, F., Schmidt, E., Zeleznik, L., Roe, B.A., Burian, D. and Domer, P.H. (1998) Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints. Leukemia, 12, 1895-1902.
doi.org/10.1038/sj.leu.2401223
|
[27]
|
Odero, M.D., Zeleznik, L., Chinwalla, V. and Rowley, J.D. (2000) Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation. Genes Chromosomes. Cancer, 29, 333-338.
doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z
|
[28]
|
Super, H.J., Martinez-Climent, J. and Rowley, J.D. (1995) Molecular analysis of the Mono Mac 6 cell line: detection of an MLL-AF9 fusion transcript. Blood, 85, 855-856.
|
[29]
|
Betti, C.J., Villalobos, M.J., Diaz, M.O. and Vaughan, A.T. (2003) Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. Cancer Res., 63, 1377-1381.
|
[30]
|
Yang, L., Rowe, T.C. and Liu, L.F. (1985) Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells. Cancer Res., 45, 5872-5876.
|
[31]
|
Jackson, S.P. (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis, 23, 687-696.
doi.org/10.1093/carcin/23.5.687
|
[32]
|
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A. and Nagata, S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature, 391, 43-50. doi.org/10.1038/34112
|
[33]
|
Yee, P.H. and Sim, S.P. (2010) High cell density and latent membrane protein 1 expression induce cleavage of the mixed lineage leukemia gene at 11q23 in nasopharyngeal carcinoma cell line. J. Biomed. Sci., 17, 77.
doi.org/10.1186/1423-0127-17-77
|
[34]
|
Lechardeur, D., Xu, M. and Lukacs, G.L. (2004) Contrasting nuclear dynamics of the caspase-activated DNase (CAD) in dividing and apoptotic cells. J. Cell Biol., 167, 851-862. doi.org/10.1083/jcb.200404105
|
[35]
|
Lagarkova, M.A., Iarovaia, O.V. and Razin, S.V. (1995) Large-scale fragmentation of mammalian DNA in the course of apoptosis proceeds via excision of chromosomal DNA loops and their oligomers. J Biol. Chem., 270, 20239-20241. doi.org/10.1074/jbc.270.35.20239
|
[36]
|
Kessel, D., Hall, T.C. and Roberts, D. (1968) Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response. Cancer Res., 28, 564-570.
|
[37]
|
Lyons, R.M. and Goldenberg, G.J. (1972) Active transport of nitrogen mustard and choline by normal and leukemic human lymphoid cells. Cancer Res., 32, 1679-1685.
|
[38]
|
Kim, D.K., Cho, E.S. and Um, H.D. (2000) Caspase-dependent and-independent events in apoptosis induced by hydrogen peroxide. Exp. Cell Res., 257, 82-88.
doi.org/10.1006/excr.2000.4868
|
[39]
|
Kitagawa, K. and Niikura, Y. (2008) Caspase-independent mitotic death (CIMD). Cell Cycle, 7, 1001-1005. doi.org/10.4161/cc.7.8.5720
|
[40]
|
Samejima, K., Tone, S. and Earnshaw, W.C. (2001) CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis. J Biol. Chem., 276, 45427-45432.
doi.org/10.1074/jbc.M108844200
|
[41]
|
Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Brothers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D.R., Aebersold, R., Siderovski, D.P., Penninger, J.M. and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-446. doi.org/10.1038/17135
|
[42]
|
Li, L.Y., Luo, X. and Wang, X. (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 412, 95-99. doi.org/10.1038/35083620
|
[43]
|
van Loo, G., Schotte, P., van Gurp, M., Demol, H., Hoorelbeke, B., Gevaert, K., Rodriguez, I., Ruiz-Carrillo, A., Vandekerckhove, J., Declercq, W., Beyaert, R. and Vandenabeele, P. (2001) Endonuclease G: a mitochondrial protein released in apoptosis and involved in cas-pase-independent DNA degradation. Cell Death. Differ., 8, 1136-1142. doi.org/10.1038/sj.cdd.4400944
|
[44]
|
Widlak, P., Li, L.Y., Wang, X. and Garrard, W.T. (2001) Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J. Biol. Chem., 276, 48404-48409.
|
[45]
|
Strick, R., Strissel, P.L., Borgers, S., Smith, S.L. and Rowley, J.D. (2000) Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. U. S. A, 97, 4790-4795.
doi.org/10.1073/pnas.070061297
|
[46]
|
Solovyan, V.T., Bezvenyuk, Z.A., Salminen, A., Austin, C.A. and Courtney, M.J. (2002) The role of topoisomerase II in the excision of DNA loop domains during apoptosis. J Biol. Chem., 277, 21458-21467.
doi.org/10.1074/jbc.M110621200
|
[47]
|
Earnshaw, W.C., Halligan, B., Cooke, C.A., Heck, M.M. and Liu, L.F. (1985) Topoisomerase II is a structural component of mitotic chromosome scaffolds. J. Cell Biol., 100, 1706-1715. doi.org/10.1083/jcb.100.5.1706
|
[48]
|
Durrieu, F., Samejima, K., Fortune, J.M., Kandels-Lewis, S., Osheroff, N. and Earnshaw, W.C. (2000) DNA topoisomerase IIalpha interacts with CAD nuclease and is involved in chromatin condensation during apoptotic execution. Curr. Biol., 10, 923-926.
doi.org/10.1016/S0960-9822(00)00620-5
|
[49]
|
Laemmli, U.K., Kas, E., Poljak, L. and Adachi, Y. (1992) Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev., 2, 275-285.
doi.org/10.1016/S0959-437X(05)80285-0.
|